160 related articles for article (PubMed ID: 32553285)
1. Meningioma: Signaling pathways and tumor growth.
Burnett BA; Womeldorff MR; Jensen R
Handb Clin Neurol; 2020; 169():137-150. PubMed ID: 32553285
[TBL] [Abstract][Full Text] [Related]
2. Aberrant signaling pathways in meningiomas.
Ragel BT; Jensen RL
J Neurooncol; 2010 Sep; 99(3):315-24. PubMed ID: 20838852
[TBL] [Abstract][Full Text] [Related]
3. C-erbB2/HER2 in human gliomas, medulloblastomas, and meningiomas: a minireview.
Waage IS; Vreim I; Torp SH
Int J Surg Pathol; 2013 Dec; 21(6):573-82. PubMed ID: 23842006
[TBL] [Abstract][Full Text] [Related]
4. Tumor extension in high-grade gliomas assessed with diffusion magnetic resonance imaging: values and lesion-to-brain ratios of apparent diffusion coefficient and fractional anisotropy.
van Westen D; Lätt J; Englund E; Brockstedt S; Larsson EM
Acta Radiol; 2006 Apr; 47(3):311-9. PubMed ID: 16613314
[TBL] [Abstract][Full Text] [Related]
5. Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.
Guastella AR; Michelhaugh SK; Klinger NV; Fadel HA; Kiousis S; Ali-Fehmi R; Kupsky WJ; Juhász C; Mittal S
J Neurooncol; 2018 Sep; 139(2):239-249. PubMed ID: 29667084
[TBL] [Abstract][Full Text] [Related]
6. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY
J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
[TBL] [Abstract][Full Text] [Related]
7. Expressions of Endocan in Patients with Meningiomas and Gliomas.
Atukeren P; Kunbaz A; Turk O; Kemerdere R; Ulu MO; Turkmen Inanir N; Tanriverdi T
Dis Markers; 2016; 2016():7157039. PubMed ID: 27528791
[TBL] [Abstract][Full Text] [Related]
8. Nrf2 Expressions Correlate with WHO Grades in Gliomas and Meningiomas.
Tsai WC; Hueng DY; Lin CR; Yang TC; Gao HW
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187376
[TBL] [Abstract][Full Text] [Related]
9. Forkhead Box M1 promotes the growth and tube formation of human malignant meningioma cells via the aryl hydrocarbon receptor signaling pathway.
Wu Q; Zheng J; Dou C; Qi S
Folia Neuropathol; 2020; 58(3):223-236. PubMed ID: 33099292
[TBL] [Abstract][Full Text] [Related]
10. The expression of hypoxia-inducible factor-1 in primary brain tumors.
Reszec J; Rutkowski R; Chyczewski L
Int J Neurosci; 2013 Sep; 123(9):657-62. PubMed ID: 23550771
[TBL] [Abstract][Full Text] [Related]
11. Molecular imaging correlates of tryptophan metabolism via the kynurenine pathway in human meningiomas.
Bosnyák E; Kamson DO; Guastella AR; Varadarajan K; Robinette NL; Kupsky WJ; Muzik O; Michelhaugh SK; Mittal S; Juhász C
Neuro Oncol; 2015 Sep; 17(9):1284-92. PubMed ID: 26092774
[TBL] [Abstract][Full Text] [Related]
12. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema.
Nassehi D
Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727
[TBL] [Abstract][Full Text] [Related]
13. Exploring the role of epidermal growth factor receptor variant III in meningeal tumors.
Rana R; Rathi V; Chauhan K; Jain K; Chhabra SS; Acharya R; Kalra SK; Gupta A; Jain S; Ganguly NK; Yadav DK
PLoS One; 2021; 16(9):e0255133. PubMed ID: 34582442
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor receptor in meningiomas is expressed predominantly on endothelial cells.
Shiurba RA; Eng LF; Vogel H; Lee YL; Horoupian DS; Urich H
Cancer; 1988 Nov; 62(10):2139-44. PubMed ID: 3052782
[TBL] [Abstract][Full Text] [Related]
15. The association of osteopontin and LMX1A expression with World Health Organization grade in meningiomas and gliomas.
Tsai WC; Lee HS; Lin CK; Chen A; Nieh S; Ma HI
Histopathology; 2012 Nov; 61(5):844-56. PubMed ID: 22882568
[TBL] [Abstract][Full Text] [Related]
16. ARID4B is a good biomarker to predict tumour behaviour and decide WHO grades in gliomas and meningiomas.
Tsai WC; Hueng DY; Nieh S; Gao HW
J Clin Pathol; 2017 Feb; 70(2):162-167. PubMed ID: 27451434
[TBL] [Abstract][Full Text] [Related]
17. Tumor infiltrating immune cells in gliomas and meningiomas.
Domingues P; González-Tablas M; Otero Á; Pascual D; Miranda D; Ruiz L; Sousa P; Ciudad J; Gonçalves JM; Lopes MC; Orfao A; Tabernero MD
Brain Behav Immun; 2016 Mar; 53():1-15. PubMed ID: 26216710
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor binding in intracranial neoplasms: preliminary biochemical and clinicopathological findings.
Whittle IR; Hawkins RA; Killen E; Miller JD
Br J Neurosurg; 1988; 2(2):211-5. PubMed ID: 3267305
[TBL] [Abstract][Full Text] [Related]
19. [Immunohistochemical study of extracellular matrices in human glioma and meningioma].
Wang L; Liang Y
Zhonghua Yi Xue Za Zhi; 1991 Feb; 71(2):81-3, 8. PubMed ID: 1647841
[TBL] [Abstract][Full Text] [Related]
20. [DNA synthesis activity and growth fractions of brain tumors].
Kunz J; Schmidt A; Jänisch W
Acta Histochem Suppl; 1992; 42():165-70. PubMed ID: 1584961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
